United States-based CVS Health (NYSE: CVS) is to provide COVID-19 vaccinations to long-term care facilities throughout the United States when a vaccine becomes available, it was reported on Friday.
CVS Health says that it has the experience and expertise to play a vital role in the COVID-19 vaccination effort. It quickly mobilised its colleagues and resources to provide COVID-19 testing sites in the country and have now administered over five million COVID tests.
Troyen Brennan, MD, chief medical officer, CVS Health, said, 'CVS Health has been on the front lines of the fight against COVID-19, working across the health care spectrum in all the communities we serve and that will continue to be the case when we have a vaccine to administer. Our nation's elderly living in long-term care facilities are one of the most vulnerable populations. With early access to a vaccination, we can help keep them, and the staff caring for them, healthy and safe.'
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio
GSK and IQVIA expand vaccine track with local data to drive targeted public health action
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate